Weissert, Robert
Cleveland Clinic
3 papers on CoChatORCID 0000-0002-1295-1271
Most cited papers
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified
Neurofilament ELISA validation
Petzold, A., Altintas, A., Andreoni, L., Bartos, A., Berthele, A., Blankenstein, M. A., Buee, L., Castellazzi, M., Cepok, S., Comabella, M., et al. (2010) · Journal of Immunological Methods
Clinical Laboratory Practices and Quality ControlReliability and Agreement in Measurement
Cited by 105
- Verified
Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant
Jagessar, S. A., Heijmans, N., Blezer, E. L. A., Bauer, J., Weissert, R., & ‘t Hart, B. A. (2015) · Journal of Neuroinflammation
Multiple Sclerosis Research StudiesT-cell and B-cell Immunology
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free